A prospective study to evaluate feasibility of dynamic contrast enhanced ultrasound in predicting treatment response of high-intensity focused ultrasound in patients with locally advanced pancreatic cancer lesions
Latest Information Update: 10 Jun 2021
At a glance
- Drugs Sulfur hexafluoride (Primary)
- Indications Pancreatic cancer
- Focus Diagnostic use
- 10 Jun 2021 New trial record